State Street’s Apexigen, Inc. Common Stock APGN Stock Holding History

State Street’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-54,300	Closed	-$23.3K	–	4675
2023 Q2	$23.3K	Hold	54,300	–	–	﹤0.01%	4576
2023 Q1	$27.1K	Hold	54,300	–	–	﹤0.01%	4637
2022 Q4	$37.5K	Hold	54,300	–	–	﹤0.01%	4621
2022 Q3	$147K	Buy	+54,300	New	+$442K	﹤0.01%	4274

State Street's APGN Position: Q3 2023 in Review

State Street sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2023, closing a stake of 54,300 shares — an estimated $23.3K sold.

State Street first reported a position in APGN in Q3 2022 and held it in 4 quarters. The position peaked at $147K in Q3 2022. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

State Street reported no remaining Apexigen, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
State Street sold 54,300 Apexigen, Inc. Common Stock shares in Q3 2023, an estimated $23.3K.
State Street first reported a position in Apexigen, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
State Street's Apexigen, Inc. Common Stock position peaked at $147K in Q3 2022.
0 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.